244 related articles for article (PubMed ID: 26259977)
1. HGF mediated upregulation of lipocalin 2 regulates MMP9 through nuclear factor-κB activation.
Koh SA; Lee KH
Oncol Rep; 2015 Oct; 34(4):2179-87. PubMed ID: 26259977
[TBL] [Abstract][Full Text] [Related]
2. Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
Chung IH; Chen CY; Lin YH; Chi HC; Huang YH; Tai PJ; Liao CJ; Tsai CY; Lin SL; Wu MH; Chen CY; Lin KH
Oncotarget; 2015 Jun; 6(17):15050-64. PubMed ID: 25940797
[TBL] [Abstract][Full Text] [Related]
3. Lipocalin 2 promotes the migration and invasion of esophageal squamous cell carcinoma cells through a novel positive feedback loop.
Du ZP; Wu BL; Xie YM; Zhang YL; Liao LD; Zhou F; Xie JJ; Zeng FM; Xu XE; Fang WK; Li EM; Xu LY
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2240-50. PubMed ID: 26190820
[TBL] [Abstract][Full Text] [Related]
4. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
[TBL] [Abstract][Full Text] [Related]
5. HGF-mediated Up-regulation of PHLDA2 Is Associated With Apoptosis in Gastric Cancer.
Koh SA; Lee KH
Anticancer Res; 2021 Sep; 41(9):4377-4385. PubMed ID: 34475057
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
7. Lipocalin-2 elicited by advanced glycation end-products promotes the migration of vascular smooth muscle cells.
Chung TW; Choi HJ; Kim CH; Jeong HS; Ha KT
Biochim Biophys Acta; 2013 Dec; 1833(12):3386-3395. PubMed ID: 24149112
[TBL] [Abstract][Full Text] [Related]
8. Lipocalin2 enhances the matrix metalloproteinase-9 activity and invasion of extravillous trophoblasts under hypoxia.
Kobara H; Miyamoto T; Suzuki A; Asaka R; Yamada Y; Ishikawa K; Kikuchi N; Ohira S; Shiozawa T
Placenta; 2013 Nov; 34(11):1036-43. PubMed ID: 23972287
[TBL] [Abstract][Full Text] [Related]
9. Induction of lipocalin-2 expression in acute and chronic experimental liver injury moderated by pro-inflammatory cytokines interleukin-1β through nuclear factor-κB activation.
Borkham-Kamphorst E; Drews F; Weiskirchen R
Liver Int; 2011 May; 31(5):656-65. PubMed ID: 21457438
[TBL] [Abstract][Full Text] [Related]
10. Kiss-1 suppresses MMP-9 expression by activating p38 MAP kinase in human stomach cancer.
Lee KH; Kim JR
Oncol Res; 2009; 18(2-3):107-16. PubMed ID: 20066900
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.
Leng X; Ding T; Lin H; Wang Y; Hu L; Hu J; Feig B; Zhang W; Pusztai L; Symmans WF; Wu Y; Arlinghaus RB
Cancer Res; 2009 Nov; 69(22):8579-84. PubMed ID: 19887608
[TBL] [Abstract][Full Text] [Related]
12. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans.
Catalán V; Gómez-Ambrosi J; Rodríguez A; Ramírez B; Silva C; Rotellar F; Gil MJ; Cienfuegos JA; Salvador J; Frühbeck G
J Mol Med (Berl); 2009 Aug; 87(8):803-13. PubMed ID: 19466389
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic induction of epithelial to mesenchymal transition by LCN2 mediates metastasis and tumorigenesis, which is abrogated by NF-κB inhibitor BRM270 in a xenograft model of lung adenocarcinoma.
Mongre RK; Sodhi SS; Sharma N; Ghosh M; Kim JH; Kim N; Park YH; Shin YG; Kim SJ; Jiao ZJ; Huynh do L; Jeong DK
Int J Oncol; 2016 Jan; 48(1):84-98. PubMed ID: 26573874
[TBL] [Abstract][Full Text] [Related]
14. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
15. ER stress drives Lipocalin 2 upregulation in prostate cancer cells in an NF-κB-dependent manner.
Mahadevan NR; Rodvold J; Almanza G; Pérez AF; Wheeler MC; Zanetti M
BMC Cancer; 2011 Jun; 11():229. PubMed ID: 21649922
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of lipocalin-2 suppresses the growth and invasion of prostate cancer cells.
Tung MC; Hsieh SC; Yang SF; Cheng CW; Tsai RT; Wang SC; Huang MH; Hsieh YH
Prostate; 2013 Sep; 73(12):1281-90. PubMed ID: 23775308
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin 2: a multifaceted modulator of human cancer.
Yang J; Moses MA
Cell Cycle; 2009 Aug; 8(15):2347-52. PubMed ID: 19571677
[TBL] [Abstract][Full Text] [Related]
18. Lipocalin 2 is a regulator of macrophage polarization and NF-κB/STAT3 pathway activation.
Guo H; Jin D; Chen X
Mol Endocrinol; 2014 Oct; 28(10):1616-28. PubMed ID: 25127375
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1.
Mir SU; Jin L; Craven RJ
J Biol Chem; 2012 Apr; 287(18):14494-501. PubMed ID: 22418433
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic cancer cells.
Tong Z; Chakraborty S; Sung B; Koolwal P; Kaur S; Aggarwal BB; Mani SA; Bresalier RS; Batra SK; Guha S
Cancer; 2011 Jun; 117(11):2408-18. PubMed ID: 24048788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
